PT  - JOURNAL ARTICLE
AU  - Buckley, Rita
ED  - Montalescot, Gilles
TI  - Eplerenone Post Myocardial Infarction Plus Standard Treatment May Prevent Adverse Cardiovascular Outcomes
DP  - 2013 May 01
TA  - MD Conference Express
PG  - 20--21
VI  - 13
IP  - 2
4099  - http://mdc.sagepub.com/content/13/2/20.short
4100  - http://mdc.sagepub.com/content/13/2/20.full
AB  - Early administration of eplerenone added to standard treatment in postmyocardial infarction patients appears to reduce the risk of adverse cardiovascular outcomes and heart failure, according to results from the Impact of Eplerenone on Cardiovascular Outcomes in Patients Post-Myocardial Infarction trial [REMINDER; NCT01176968].